Current QIMR Berghofer appointment
- Team Head, Health Economics group, QIMR Berghofer.
Over the past 5 years she have been chief investigator on competitive research grants totalling over $5 million from the NHMRC & ARC and on research consultancies totalling over $5.2 million including reports to decision-makers at the Department of health. Her research addresses the societal cost of health issues and the cost-effectiveness of health interventions and technologies.
During the course of her research career Louisa have worked on projects covering a wide range of health issues such as behaviour change interventions during cancer survivorship, genetic testing, work loss following colorectal cancer and the economics of ultraviolet radiation on health. This research is conducted in collaboration with clinicians and health policymakers to facilitate translation of research outcomes and communication to relevant stakeholders.
Her current projects involve evaluating clinical genomics, modelling the healthcare costs of cancers, investigating the ‘financial toxicity’ of cancer care and assessing the cost-effectiveness of support interventions for cancer survivors across various projects
Since 2017, Louisa have received funding from the Queensland Genomics to lead the Evaluation of Clinical Genomics project. This involves building evaluation activities into the clinical implementation projects which will integrate genomic testing in various patient groups and develop a framework for valuing clinical genomics.
Evaluation of clinical genomics involving 4 demonstration projects:
- Whole genome sequencing of serious bacterial infections for hospitalised patients to prevent or delay hospital outbreaks
- Panel testing of patients with myeloid blood cancers
- Whole exome sequencing for patients with refractory epilepsy
- Whole genome sequencing for patients with paediatric genetic conditions
F-NET – Financial impacts of patients with neuroendocrine tumours
Using hybrid simulation modelling to evaluate a risk assessment tool to improve triaging of patients referred to hospital for colonoscopy
Nurse practitioner endoscopy versus medical endoscopy – comparison of quality, effectiveness and economic impacts
Decision support intervention for men with early stage prostate cancer
Telehealth delivered psychosocial support for patients with brain tumours
Teledermatology interventions for patients at extreme risk of melanoma
Risk-stratified screening for patients at high risk for liver cancer
Economics of organ transplantation and skin cancers
Economic impacts of regulation to limit indoor tanning behaviours to prevent skin cancers
Cost-effectiveness of a decision aid to help men with low-risk prostate cancer decide between active treatment or active surveillance (NAVIGATE).
Other current appointments
- Adjunct Associate Professor – QUT & UQ
- Principal Research Fellow – Griffith University
- Post-doctoral Research Fellow – QIMR
- Health Economist – Cancer Council Queensland
Current Area of Research
- Economic evaluation
- Decision-analytic modelling
- Cancer interventions
- Evaluation of clinical genomics projects in Queensland
- Pilot evaluation of the Nurse Navigator program in Queensland Health
- Using a hybrid simulation model to examine a risk assessment tool to improve triaging patients referred for colonoscopies
- Within-trial cost-effectiveness analysis of a decision aid and DVD information support for men diagnosed with low-risk prostate cancer
- Costs of Surviving Cancer – a Queensland study (COS-Q)
- Pilot evaluation of the transplant skin clinic project
- 2019-2021 Queensland Genomics Round 2 CI-A Gordon LG Evaluation of Clinical Genomic (capability infrastructure) Funding: $563,000
- 2018-2022 NHMRC Partnership Grant #1152217 Ownsworth T, Chambers S, Aitken J, Foote M, Shum D, CI-F Gordon L ‘Evaluation of a telehealth intervention for delivering psychosocial support to people with brain tumour and their families’ ($377,000)
- 2018-2022 NHMRC Partnership Grant #1152217 Soyer P, CI-B Gordon L, Aitken J, Osborne S, Whiteman D, Finane A, Eakin L, Gray L, McCaffery L, Janda M. ‘Evaluation of targeted screening in high risk melanoma patients using: 3D full body imaging, genomic risk assessment and functional testing of gene variants. 2018-2022 ($1,200,000)
- 2017-2018 Queensland Genomics Round 1 CI-A Gordon LG, Co-investigators: Graves N, Webb P, Lakhani S, Griffiths L, Spurdle A, Waddell N, Schofield D, Shrestha R, Cunich M, Khurshid A, Tan O, Rynehart L, Lymer S, West S. Evaluation of Clinical Genomic Projects in Action in Queensland. 2017-2018 $480,000
- 2015-2018 NHMRC Project Grant #1079720 – Schofield P, Chambers SK, Juraskona I, CI-E Gordon LG, Gardiner F. ‘ASTROID: Active Surveillance and other TReatment OptIons for prostate cancer. An RCT of decision aid and DVD information support for men diagnosed with low-risk prostate cancer.’ ($749,704)
- Australian Red Cross Blood Service Gordon L. ‘Economic analysis of RHD genotyping to target pregnant women for antenatal and post-partum anti-D prophylaxis ($20,000)
- Rodriguez-Acevedo AJ, Green AC, Sinclair C, van Deventer E, Gordon LG. Indoor tanning prevalence after the International Agency for Research on Cancer’s statement on carcinogenicity of artificial tanning devices: systematic review and meta-analysis. Br J Dermatol; Aug 2019 doi: 10.1111/bjd.18412.
- Ownsworth T, Chambers S, Aitken J, Foote M, Pinkham MB, Gordon LG, Shum D, Locke G, Hanley G, Gardner T, Jones S, Robertson J and Conlon Evaluation of a telehealth psychological support intervention for people with primary brain tumour and their family members: Study protocol for a randomised controlled trial. Euro J Can Care 2019 Jul;28(4):e13132. doi: 10.1111/ecc.13132
- Turner J, Yates P, Kenny L, Gordon LG, Burmeister B, Hughes BG ; McCarthy A; Perry C; Chan RJ; Paviour A; Skerman H; Batstone M; Mackenzie L. The ENHANCES study: a randomized controlled trial of a nurse-led survivorship intervention for patients treated for head and neck cancer. Supportive Care Cancer 2019 Apr 2. doi: 10.1007/s00520-019-04748-7.
- Elliott TM, Lord A, Simms LA, Radford-Smith G, Valery PC, Gordon LG. Evaluating a risk assessment tool to improve triaging of patients to colonoscopies. Internal Medicine Journal. 2019 Feb 28. doi: 10.1111/imj.14267.
- DC Whiteman, RE Neale, J Aitken, L Gordon, AC Green, M Janda, Catherine M Olsen, H Peter Soyer, Sunscreen Summit Policy Group When to apply sunscreen: a consensus statement for Australia and New Zealand ANZJPH 2019; 43 (2), 171-175.
- Gordon LG, Rodriguez A, Papier K, Khosrotehrani K, Isbel N , Campbell S, Griffin A , Green AC. The effects of a multidisciplinary high-throughput skin clinic on healthcare costs of organ transplant recipients. J Euro Acad Derm Venerol. 2019 Jul;33(7):1290-1296.
- Chan RJ, Gordon LG, Tan CJ, Chan A, Bradford NK, Yates P, Agbejule OA, Miaskowski C. Relationships between Financial Toxicity and Symptom Burden in Cancer Survivors: A Systematic Review. J Pain Symp Mgmnt 2019 Mar;57(3):646-660.e1.
- Gordon LG, Spooner AJ, Booth N, Downer T, Hudson AP, Yates P, Geary A, O’Donnell C, Chan RJ. Do nurse navigators bring about fewer patient hospitalisations? J Health Org Mgmnt 2019 Mar 18;33(1):51-62.
- Gordon LG, Elliott T, Olsen C, Pandeya N, Whiteman DC. Patient out-of-pocket medical expenses over two years among Queenslanders with and without a major cancer’ Australian Journal of Primary Health. 2018; 24(6); 530-536.
- Papier K, Gordon LG, Khosrotehrani K, Isbel N , Campbell S, Griffin A , Green AC. Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland Br J Dermatol. 2019 Mar;180(3):631-636.
Publication summary: Of 149 career publications, 115 are journal publications including papers in Value in Health, Med J Aust, Br J Surg, JAMA Dermatol, Ann Oncol, J Invest Dermatol, and 58 of the journal publications are in the last 5 years (2015 onwards). For the Department of Health, she have overseen or led 30 major reports for MSAC and PBAC. She have given 49 conference presentations (6 keynote/plenary talks & 10 invited speaker talks) and written 5 chapters, 3 in Australian clinical practice guidelines. My career H-index is 27 and i10 index 57 (Google Scholar) with 2047 citations. Since 2014, my published articles have 1563 citations and an H-index of 22.
- Lead a systematic review of financial toxicity among cancer survivors – published in The Patient – Patient-Centred Outcomes Research 2017; 1-15. This was an invited article where she was seen as a leader on this topic. It has received much attention and support by psychosocial health researchers and 15 citations in the first 9 months of publication.
- Contributed to Australian clinical practice guidelines for the diagnosis and management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma. This has been disseminated via Cancer Australia online networds and published in J Gastroenterol Hepatol. 2015; 30(5)804-820. 32 citations. This guidelines paper was the result of a working party of clinicians and researchers specifically designed to influence clinical practice in this field in Australia and internationally.
- Lead a systematic review on the health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening – published in European Journal of Cancer Prevention 2015; 21(2),141-149. 45 citations This is the first review of the economic evidence of skin cancer globally and was repeatedly quoted and highlighted at the 3rd International Conference in UV and Skin Cancer Prevention.I was asked to present this at a WHO meeting (remotely) in Belgium 2016.
- During 2007-2008, published a major report and several publications later on the harms of solaria use in Australia and economic impacts of regulation. This body of work contributed to legislation passed in all State parliaments of Australia which now bans the use of commercial solaria businesses.
- 2017 – current: Queensland Collaborative for Cancer Survivorship www.qccs.org.au
- 2017 – current: BDHP theme ‘Evidence & Innovation in Clinical Care’ http://www.brisbanediamantina.com/
- 2017 – current: Health Services Research Association of Australia and New Zealand
- 2013 – current: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Aust. Chapter.
- 2008 – current: International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
- 2013: International Health Economics Society.
- 2007: Psycho-Oncology Cooperative Research Group.
- 2017 Best Abstract of HSRAANZ Conference – Co-author and supervisor of 1st author
- 2015 Vice Chancellors Research Excellence Award for a Team, Griffith University
- 2015 Pro Vice Chancellors (Health) Research Excellence Award for a Team, Griffith University
- 2015 1st Place Poster Award at Prostate Cancer World Congress (Clinical Urology)
- 2013 Griffith University Publication of the Year, Population and Social Health Research Program
- 2008-2012 NHMRC Public Health Early Career Fellowship #496714
- PhD (Public Health), Queensland University of Technology.
- Master of Public Health, Queensland University of Technology.
- Bachelor of Economics (Economics major) University of New England.